|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/09/16 American Renal Assocs Holdin… Inc 10-Q 6/30/16 58:5.7M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 779K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
12: R1 Document and Entity Information HTML 38K
13: R2 Consolidated Balance Sheets HTML 109K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K
15: R4 Consolidated Statements of Operations HTML 83K
16: R5 Consolidated Statements of Comprehensive Income HTML 32K
(Loss)
17: R6 Consolidated Statements of Changes in Equity HTML 85K
18: R7 Consolidated Statements of Changes in Equity HTML 21K
(Parenthetical)
19: R8 Consolidated Statements of Cash Flows HTML 134K
20: R9 Basis of Presentation and Organization HTML 42K
21: R10 Accounts Receivable HTML 24K
22: R11 Acquisitions HTML 35K
23: R12 Fair Value Measurements HTML 121K
24: R13 Accrued Expenses and Other Current Liabilities HTML 45K
25: R14 Variable Interest Entities HTML 28K
26: R15 Noncontrolling Interests Subject to Put Provisions HTML 23K
27: R16 Debt HTML 75K
28: R17 Income Taxes HTML 23K
29: R18 Stock-Based Compensation HTML 73K
30: R19 Earnings Per Share HTML 103K
31: R20 Related Party Transactions HTML 35K
32: R21 Commitments and Contingencies HTML 29K
33: R22 Subsequent Events HTML 19K
34: R23 Basis of Presentation and Organization (Policies) HTML 44K
35: R24 Acquisitions (Tables) HTML 27K
36: R25 Fair Value Measurements (Tables) HTML 114K
37: R26 Accrued Expenses and Other Current Liabilities HTML 46K
(Tables)
38: R27 Debt (Tables) HTML 62K
39: R28 Stock-Based Compensation (Tables) HTML 63K
40: R29 Earnings Per Share (Tables) HTML 100K
41: R30 Basis of Presentation and Organization (Details) HTML 74K
42: R31 Accounts Receivable (Details) HTML 27K
43: R32 Acquisitions (Details) HTML 31K
44: R33 Fair Value Measurements (Details) HTML 70K
45: R34 Accrued Expenses and Other Current Liabilities HTML 35K
(Details)
46: R35 Variable Interest Entities Loans (Details) HTML 24K
47: R36 Noncontrolling Interests Subject to Put Provisions HTML 22K
(Details)
48: R37 Debt (Details) HTML 59K
49: R38 Debt - Credit And Interest Rate Swap Agreements HTML 89K
(Details)
50: R39 Income Taxes (Details) HTML 23K
51: R40 Stock-Based Compensation (Details) HTML 86K
52: R41 Earnings Per Share (Details) HTML 54K
53: R42 Related Party Transactions (Details) HTML 66K
54: R43 Commitments and Contingencies (Details) HTML 26K
55: R44 Subsequent Events (Details) HTML 19K
57: XML IDEA XML File -- Filing Summary XML 98K
56: EXCEL IDEA Workbook of Financial Reports XLSX 59K
6: EX-101.INS XBRL Instance -- c068-20160630 XML 1.15M
8: EX-101.CAL XBRL Calculations -- c068-20160630_cal XML 150K
9: EX-101.DEF XBRL Definitions -- c068-20160630_def XML 385K
10: EX-101.LAB XBRL Labels -- c068-20160630_lab XML 1.04M
11: EX-101.PRE XBRL Presentations -- c068-20160630_pre XML 715K
7: EX-101.SCH XBRL Schema -- c068-20160630 XSD 112K
58: ZIP XBRL Zipped Folder -- 0001498068-16-000011-xbrl Zip 119K
| ara_Ex32-1 |
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Renal Associates Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph A. Carlucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
|
|
|
|
Chief Executive Officer |
||
Date: August 9, 2016
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.